Neurocrine Biosciences Announces Conference Call and Webcast to Present
Fourth Quarter and Year-End 2002 Financial Results and Company Update
Fourth Quarter and Year-End 2002 Financial Results and Company Update
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report fourth quarter and year-end 2002 financial results after the Nasdaq market closes today, Monday, February 3, 2003. Neurocrine will also host a live Webcast to discuss its financial results and provide a company update tomorrow morning, Tuesday, February 4, 2003 at 9:00 AM Eastern Standard Time (EST) / 6:00 AM Pacific Standard Time (PST). Participants may access the live Conference Call by dialing 1-800-245-3043 (U.S.) or 1-785-830-1959 (International). The call can also be accessed via the Webcast through the Company's website at http://www.neurocrine.com or alternatively through a link provided by PRNewswire at http://www.firstcallevents.com/service/ajwz373451149gf12.html .
Gary A. Lyons, President and CEO of Neurocrine Biosciences and Paul W. Hawran, Executive Vice President and CFO will present the financial results for year-end 2002 and will discuss the Company's strategy in place for 2003. In addition, other members of Neurocrine's senior management team will provide an overview on Neurocrine's development program. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600. A replay of the Conference Call will be available by dialing 1-800-283-8486 (US) or 1-402-220-0869 (International) and will be archived until Tuesday, February 18, 2003.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
SOURCE Neurocrine Biosciences, Inc.